8
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      International Journal of COPD (submit here)

      This international, peer-reviewed Open Access journal by Dove Medical Press focuses on pathophysiological processes underlying Chronic Obstructive Pulmonary Disease (COPD) interventions, patient focused education, and self-management protocols. Sign up for email alerts here.

      39,063 Monthly downloads/views I 2.893 Impact Factor I 5.2 CiteScore I 1.16 Source Normalized Impact per Paper (SNIP) I 0.804 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Letter to the Editor, International Journal of COPD [Response to Letter]

      reply

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Dear editor We appreciate the observations of Prof. Miller and colleagues about our article recently published in the International Journal of COPD.1 The authors feel that our conclusions are not supported by data, based on two main arguments. The first is that concordant and discordant patients are different. This is obvious, and in fact, extensively detailed in our study. It seems that the authors erroneously suggest that our study is penalized by selection bias since concordant and discordant groups are quite dissimilar. In fact, we just compared two different ways of defining airway obstruction in the same prospective cohort, in a similar approach to that used by Prof. Miller et al in a previous publication.2 Regrettably, in their study, the lack of longitudinal follow-up prevented drawing valid conclusions about the evolution of the patients. Our data suggest that LLN is usually a more restrictive criterion and may misclassify patients with less severe disease. This explains the differences observed during the follow-up in hospitalizations and the COPD mortality after age-adjustment. Our results and those of several previous articles confirm that some patients classified as non-obstructive and therefore without COPD by LLN in fact present severe exacerbations and COPD mortality during follow-up.3,4 The second argument is that in patients with advanced COPD, the FEV1/FVC ratio can become artificially increased by premature distal airway closure in the spirometric evaluation of vital capacity with forced spirometry. However, the statement that in our study deterioration of pulmonary function was analyzed by the decline of FEV1/FVC ratio is incorrect. The loss of pulmonary function was measured with FEV1 (see Figure 3). It is true that the annualized FEV1/FVC ratio decreased more in discordant patients during follow-up. Nevertheless, the most relevant data concerning this argument—and not mentioned by the authors of the letter—is that 81% of discordant patients in the initial spirometry became concordant during follow-up. Since the two spirometric measures were performed in a similar manner, the fact that a considerable proportion of initially discordant patients developed obstruction by both criteria during the follow-up suggests that the exclusive use of LLN delayed the diagnosis. In our opinion, this is independent of the premature distal airway closure, which in any case should be similar in the two spirometric measurements. Finally, a few additional considerations. FR and LLN are two ways to artificially divide a continuous variable (FEV1/FVC), and therefore rather than two different diagnostic criteria, FR and LLN represent two different points to dichotomize the same variable. Since COPD is a progressive disease, before reaching the formal threshold of airway obstruction, either by FR or LLN, FEV1/FVC must decline progressively. It is well-known that many non-obstructive patients had radiological involvement on CT preceding by years the accepted definition of airway obstruction, in what some authors have labelled “pre-COPD”.5,6 In other words, in the absence of a biomarker, COPD is diagnosed when functional (airway obstruction) or radiological involvement becomes evident. For this reason, we compare two different cutoffs for the same variable, our conclusions are prudent - LLN seems to be less useful for COPD diagnosis in primary care - and we do not state at any point that our data “clearly demonstrate” that FR is superior to LLN, as the authors of the letter suggest.

          Most cited references6

          • Record: found
          • Abstract: not found
          • Article: not found

          Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease

            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Discriminative Accuracy of FEV1:FVC Thresholds for COPD-Related Hospitalization and Mortality

            Question What is the discriminative accuracy of various thresholds for the ratio of the forced expiratory volume in the first second to the forced vital capacity (FEV 1 :FVC) for predicting chronic obstructive pulmonary disease (COPD)-related hospitalization and mortality? Findings Among 24 207 participants from 4 US general population–based cohorts, the optimal fixed threshold for discriminating COPD-related events was 0.71 (C statistic for the optimal fixed threshold, 0.696). The discriminative accuracy of the 0.71 threshold was not significantly different than that of the 0.70 threshold (difference, 0.001) but it was more accurate than a lower-limit-of-normal threshold derived from population-based reference equations (difference between the optimal ratio threshold vs the model using the LLN threshold, 0.034). The 0.70 threshold provided optimal discrimination in a subgroup analysis of ever smokers and in adjusted models. Meaning These results support the use of FEV 1 :FVC less than 0.70 to identify individuals at risk of clinically significant COPD. Importance According to numerous current guidelines, the diagnosis of chronic obstructive pulmonary disease (COPD) requires a ratio of the forced expiratory volume in the first second to the forced vital capacity (FEV 1 :FVC) of less than 0.70, yet this fixed threshold is based on expert opinion and remains controversial. Objective To determine the discriminative accuracy of various FEV 1 :FVC fixed thresholds for predicting COPD-related hospitalization and mortality. Design, Setting, and Participants The National Heart, Lung, and Blood Institute (NHLBI) Pooled Cohorts Study harmonized and pooled data from 4 US general population–based cohorts (Atherosclerosis Risk in Communities Study; Cardiovascular Health Study; Health, Aging, and Body Composition Study; and Multi-Ethnic Study of Atherosclerosis). Participants aged 45 to 102 years were enrolled from 1987 to 2000 and received follow-up longitudinally through 2016. Exposures Presence of airflow obstruction, which was defined by a baseline FEV 1 :FVC less than a range of fixed thresholds (0.75 to 0.65) or less than the lower limit of normal as defined by Global Lung Initiative reference equations (LLN). Main Outcomes and Measures The primary outcome was a composite of COPD hospitalization and COPD-related mortality, defined by adjudication or administrative criteria. The optimal fixed FEV 1 :FVC threshold was defined by the best discrimination for these COPD-related events as indexed using the Harrell C statistic from unadjusted Cox proportional hazards models. Differences in C statistics were compared with respect to less than 0.70 and less than LLN thresholds using a nonparametric approach. Results Among 24 207 adults in the pooled cohort (mean [SD] age at enrollment, 63 [10.5] years; 12 990 [54%] women; 16 794 [69%] non-Hispanic white; 15 181 [63%] ever smokers), complete follow-up was available for 11 077 (77%) at 15 years. During a median follow-up of 15 years, 3925 participants experienced COPD-related events over 340 757 person-years of follow-up (incidence density rate, 11.5 per 1000 person-years), including 3563 COPD-related hospitalizations and 447 COPD-related deaths. With respect to discrimination of COPD-related events, the optimal fixed threshold (0.71; C statistic for optimal fixed threshold, 0.696) was not significantly different from the 0.70 threshold (difference, 0.001 [95% CI, −0.002 to 0.004]) but was more accurate than the LLN threshold (difference, 0.034 [95% CI, 0.028 to 0.041]). The 0.70 threshold provided optimal discrimination in the subgroup analysis of ever smokers and in adjusted models. Conclusions and Relevance Defining airflow obstruction as FEV 1 :FVC less than 0.70 provided discrimination of COPD-related hospitalization and mortality that was not significantly different or was more accurate than other fixed thresholds and the LLN. These results support the use of FEV 1 :FVC less than 0.70 to identify individuals at risk of clinically significant COPD. This study used harmonized and pooled data from 4 US general population–based cohorts to determine the discriminative accuracy of various FEV 1 :FVC fixed thresholds for predicting COPD-related hospitalization and mortality.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Radiographic lung volumes predict progression to COPD in smokers with preserved spirometry in SPIROMICS

              The characteristics that predict progression to overt chronic obstructive pulmonary disease (COPD) in smokers without spirometric airflow obstruction are not clearly defined. We conducted a post hoc analysis of 849 current and former smokers (≥20 pack–years) with preserved spirometry from the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS) cohort who had baseline computed tomography (CT) scans of lungs and serial spirometry. We examined whether CT-derived lung volumes representing air trapping could predict adverse respiratory outcomes and more rapid decline in spirometry to overt COPD using mixed-effect linear modelling. Among these subjects with normal forced expiratory volume in 1 s (FEV 1 ) to forced vital capacity (FVC) ratio, CT-measured residual volume (RV CT ) to total lung capacity (TLC CT ) ratio varied widely, from 21% to 59%. Over 2.5±0.7 years of follow-up, subjects with higher RV CT /TLC CT had a greater differential rate of decline in FEV 1 /FVC; those in the upper RV CT /TLC CT tertile had a 0.66% (95% CI 0.06%–1.27%) faster rate of decline per year compared with those in the lower tertile (p=0.015) regardless of demographics, baseline spirometry, respiratory symptoms score, smoking status (former versus current) or smoking burden (pack–years). Accordingly, subjects with higher RV CT /TLC CT were more likely to develop spirometric COPD (OR 5.7 (95% CI 2.4–13.2) in upper versus lower RV CT /TLC CT tertile; p<0.001). Other CT indices of air trapping showed similar patterns of association with lung function decline; however, when all CT indices of air trapping, emphysema, and airway disease were included in the same model, only RV CT /TLC CT retained its significance. Increased air trapping based on radiographic lung volumes predicts accelerated spirometry decline and progression to COPD in smokers without obstruction.
                Bookmark

                Author and article information

                Journal
                Int J Chron Obstruct Pulmon Dis
                Int J Chron Obstruct Pulmon Dis
                copd
                copd
                International Journal of Chronic Obstructive Pulmonary Disease
                Dove
                1176-9106
                1178-2005
                13 October 2020
                2020
                : 15
                : 2465-2466
                Affiliations
                [1 ]Terrassa Sud Primary Care Center, Hospital Universitari Mutua Terrassa, University of Barcelona , Barcelona, Spain
                [2 ]Fundació Docència i Recerca Mutua Terrassa , Barcelona, Spain
                [3 ]Internal Medicine Service, Hospital Universitari Mutua Terrassa, University of Barcelona , Barcelona, Spain
                Author notes
                Correspondence: Montserrat Llordés Terrassa Sud Primary Care Center, Hospital Universitari Mutua Terrassa , Avenida Santa Eulalia s/n, Terrassa, Barcelona08223, SpainTel +34 93 785 51 61Fax +34 93 731 49 52 Email mllordes@mutuaterrassa.cat
                Author information
                http://orcid.org/0000-0002-6467-4341
                http://orcid.org/0000-0002-6815-2022
                http://orcid.org/0000-0003-4388-8874
                http://orcid.org/0000-0002-8476-4942
                Article
                284309
                10.2147/COPD.S284309
                7568588
                05848a27-f8b4-4c96-ab1b-268b7a1b9794
                © 2020 Llordés et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 28 September 2020
                : 28 September 2020
                Page count
                Figures: 0, References: 6, Pages: 2
                Categories
                Response to Letter

                Respiratory medicine
                Respiratory medicine

                Comments

                Comment on this article